tiprankstipranks
Trending News
More News >
Bone Therapeutics (DE:BT1)
:BT1
Germany Market

Bone Therapeutics (BT1) Income Statement

Compare
0 Followers

Bone Therapeutics Income Statement

Last quarter (Q2 2024), Bone Therapeutics's total revenue was €2.69M, an increase of Infinity% from the same quarter last year. In Q2, Bone Therapeutics's net income was €495.00K. See Bone Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
€ 543.00K€ 266.00K€ 1.00M€ 1.00M€ 0.00
Gross Profit
€ 543.00K€ 206.00K€ 987.00K€ 1.00M€ -228.00K
Operating Expenses
€ 7.58M€ 2.32M€ 13.03M€ 16.02M€ 11.17M
Depreciation and Amortization
€ 234.00K€ 60.00K€ 13.00K€ 173.00K€ 228.00K
EBITDA
€ -6.80M€ -2.26M€ -864.00K€ -14.83M€ -6.69M
Operating Income
€ -7.04M€ -2.32M€ -12.03M€ -15.02M€ -11.17M
Other Income/Expenses
€ -21.99M€ -731.00K€ -107.00K€ -737.00K€ 3.65M
Pretax Income
€ -29.03M€ -3.05M€ -12.84M€ -15.75M€ -10.30M
Net Income
€ -28.78M€ -2.04M€ -12.93M€ -11.94M€ -10.46M
Per Share Metrics
Basic EPS
€ -0.21€ -0.02€ -0.61€ -1.02€ -1.10
Diluted EPS
€ -0.21€ -0.02€ -0.61€ -1.02€ -1.10
Weighted Average Shares Outstanding
137.04M 120.13M 21.31M 11.72M 9.54M
Weighted Average Shares Outstanding (Diluted)
137.04M 120.13M 21.31M 11.72M 9.54M
Currency in EUR

Bone Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis